PRKAA2 and lung cancer: It was demonstrated that metformin, a direct AMPK activator, induced lower levels of mTORC1, S6K1, and S6 protein phosphorylation in the combined treatment with cisplatin, besides improving the response to radiation in nonsmall lung cancer cells (48).